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CRISPR/Cas9-mediated targeted mutagenesis allows efficient generation of loss-of-function alleles in zebrafish. To date, this
technology has been primarily used to generate genetic knockout animals. Nevertheless, the study of the function of certain
loci might require tight spatiotemporal control of gene inactivation. Here, we show that tissue-specific gene disruption can
be achieved by driving Cas9 expression with the Gal4/UAS system. Furthermore, by combining the Gal4/UAS and Cre/
loxP systems, we establish a versatile tool to genetically label mutant cell clones, enabling their phenotypic analysis. Our
technique has the potential to be applied to diverse model organisms, enabling tissue-specific loss-of-function and pheno-
typic characterization of live and fixed tissues.
[Supplemental material is available for this article.]
The CRISPR (Clustered Regularly Interspaced Short Palindromic
Repeats)/CRISPR-associated (Cas) system has recently emerged as
a powerful tool to generate constitutive loss-of-function alleles,
enabling detailed analyses of gene function (Cho et al. 2013;
Cong et al. 2013; Hwang et al. 2013b; Mali et al. 2013). Gene dis-
ruption is achieved by the activity of two components: a single
guide RNA (sgRNA) that contains 20 nt complementary to a
DNA target, and a Cas9 endonuclease that catalyzes DNA cleavage
at the target site after complex formation with the sgRNA.
Following DNA cleavage, mutations are efficiently induced upon
imperfect repair by the nonhomologous end-joining (NHEJ) path-
way at the targeted sequence. sgRNAs that bind within the coding
region of a gene thereby allow disruption of the open reading
frame (ORF), leading to loss of gene activity. Pioneer studies in
worms (Shen et al. 2014), fruit fly (Port et al. 2014), mouse (Platt
et al. 2014), and, more recently, zebrafish (Ablain et al. 2015)
have taken advantage of this methodology to induce conditional
gene knockouts by driving tissue-specific expression of Cas9.
However, in zebrafish, this approach relies on cell-type–specific
promoter sequences to control Cas9 expression, usually requiring
the screening of several lines to achieve sufficient and nonectopic
transgene expression. One alternative and powerful method for
cell-specific expression of transgenes in model organisms is the
Gal4/UAS binary system (Asakawa and Kawakami 2008), in which
transcription is driven by the binding of the Gal4 transcription
factor to tandem upstream activation sequences (UAS) placed at
the 5′ end of a gene of interest. An important resource of Gal4
transgenic lines has been established by gene- and enhancer-
trap screens (Davison et al. 2007; Asakawa et al. 2008; Scott and
Baier 2009; Kawakami et al. 2010; Balciuniene et al. 2013) based
on random integration of the Gal4 ORF via Tol2 transposition
(Kawakami 2004) into the fish genome. In particular, Gal4 driver
lines have been identified for many tissues as well as for novel and
previously uncharacterized cell types, especially in the nervous
system (Scott et al. 2007; Asakawa et al. 2008). More recently, we
have developed a simple and efficient method for converting
GFP- into Gal4-transgenic lines, significantly expanding the po-
tential resource of Gal4 driver lines (Auer et al. 2014a,b). Finally,
Gal4-driven expression of transgenes from UAS promoters is ro-
bust and can often be revealed in cells whereGal4 expression itself
is difficult to detect. In this report, we show that flexible and effi-
cient gene disruption is achieved as a result of tissue-specific ex-
pression of Cas9 via the Gal4/UAS system. In addition, we
overcome the challenge of visualizing loss-of-function mutations
in specific cells by coexpressing the Cas9 endonuclease with GFP
or Cre recombinase, allowing the labeling of potentially mutant
cells and thereby facilitating their phenotypic analysis. This step
is essential to correlate phenotype with genotype for analysis of
gene function, a task that was not addressed with previously pub-
lished methods.
Results
Design of a vector system for spatiotemporal control of Cas9
activity via Gal/UAS
The generation of conditional knockout models requires the spe-
cific targeting of a gene of interest in a given tissue and, ideally,
the labeling of targeted cells. In order to develop a flexible tool
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for efficient spatiotemporal control of
gene disruption, we generated a Tol2-
based vector ensuring Gal4/UAS-mediat-
ed cell-type–specific expression of the
Cas9 enzyme and ubiquitous expression
of sgRNAs. Due to its strong transactivat-
ing properties, the Gal4/UAS system di-
rects effective expression of the Cas9
endonuclease, even in the case of weak
tissue-specific Gal4 transcription by an
endogenous promoter. Furthermore,
this system renders our vector design
compatible with many readily available
Gal4 transgenic lines generated in previ-
ous Gal4 gene- and enhancer-trap
screens (including those where the regu-
latory elements driving Gal4 expression
are not known) (Davison et al. 2007;
Asakawa et al. 2008; Scott and Baier
2009; Kawakami et al. 2010; Balciuniene
et al. 2013). In our vector design, the use
of a viral T2A self-cleaving peptide (Pro-
vost et al. 2007) to synthesize a GFP re-
porter from the same transgene (UAS:
Cas9T2AGFP) allows Cas9-positive cells
to be unambiguously marked by GFP
fluorescence. This feature is critical for
the analysis of cellular phenotypes result-
ing from Cas9-induced gene inactiva-
tion. Our vector also contains two
sgRNA expression cassettes, each driven
by the ubiquitous U6-1 promoter (Halbig
et al. 2008; Yin et al. 2015) (UAS:
Cas9T2AGFP;U6:sgRNA1;U6:sgRNA2) (Fig.
1A). By using two sgRNAs, we sought
to increase the probability of generating
loss-of-function alleles, since genomic
deletions might be induced, in addition
to frame-shifts caused by insertions
and deletions (indels). To verify that
cell-type–specific expression of Cas9
can be driven by Gal4 transcriptional
activation, we generated a stable trans-
genic line with this vector, Tg(UAS:
Cas9T2AGFP;U6:sgRNA1;U6:sgRNA2),
and crossed it to different Gal4 driver lines (Fig. 1B). The motor
neuron-specific Tg(mnx1:Gal4) transgenic line, the enhancer-trap
line Tg(s1020t) expressed in the thalamus and spinal cord, and
the optic tectum-specific gene-trap line Tg(SA2AzGFF49A) were
used as drivers. We compared the expression of the UAS:Cas9-
T2AGFP with an independent reporter of the Gal4 activity by
crossing the same driver lines with a Tg(UAS:RFP;cry:GFP). In the
embryos analyzed, GFP was specifically detected in the expected
Gal4 transactivation domain, indicating nonectopic Cas9 expres-
sion.Modest differences in GFP and RFP expressionwere observed,
the RFP-positive cells being on average more numerous than the
GFP-positive ones. This might be due to transgene specific differ-
ences likely linked to positional effect of the integration as com-
monly seen for other zebrafish transgenic lines. Overall, these
expression patterns demonstrate that our approach can be used
to both express Cas9 nuclease in a tissue-specific manner and to
simultaneously label Cas9-expressing cells with GFP.
Targeting the tyrosinase gene in the optic primordium leads to loss
of pigmentation in the retinal pigmented epithelium (RPE)
To test the efficiency of our approach for tissue-specific gene dis-
ruption, we targeted the tyrosinase (tyr) gene, which codes for a
key enzyme in melanin production (Camp and Lardelli 2001),
by including two sgRNAs targeting the tyr in our vector locus
(pUAS:Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2). We previously
assessed the mutagenesis rate of each sgRNA by injection of in vi-
tro-transcribed sgRNA with synthetic Cas9 mRNA into one-cell
stage wild-type embryos (Supplemental Table S1). Loss-of-func-
tion of the tyr locus results in pigmentation defects, offering a clear
visual read-out of biallelic gene inactivation (Jao et al. 2013). We
used fluorescence-activated cell sorting (FACS) to verify that site-
specific cleavage only occurs in GFP-expressing cells and to quan-
tify themutation rate induced by our vector. The quasi-ubiquitous
Tg(rpl5b:Gal4) line (Amsterdam et al. 2004) was chosen to enlarge
Figure 1. Spatiotemporal control of Cas9 activity via the Gal4/UAS expression system. (A) Schematic
illustration of the expression vector design. Spatial and temporal control of Cas9 synthesis is achieved by
the Gal4/UAS system andmonitored by GFP expression. Two constitutively activeU6 promoters drive the
transcription of single guide RNAs (sgRNAs) specifically targeting a gene of interest. To facilitate cloning
of sgRNA target sequences, BsmbI and BsaI restriction sites (red arrows) were introduced. Tol2 allows ef-
ficient transgenesis after injection into one-cell stage zebrafish embryos. (B) (Left panel) Confocal imaging
of the spinal cord of 2 dpf Tg(mnx1:Gal4) embryos. The upper image shows the Gal4-induced RFP expres-
sion of a double transgenic embryo deriving from a cross between Tg(mnx1:Gal4) and Tg(UAS:RFP; cry:
GFP) fish. The same pattern is observed in the GFP channel in a double transgenic Tg(mnx1:Gal4) × Tg
(UAS:Cas9T2AGFP;U6sgRNA1;U6sgRNA2) embryo (lower image). Scale bar = 100 µm. (Middle panel)
Imaging of whole-mount 3 dpf Tg(s1020t) enhancer-trap line. The GFP expression pattern (lower panel)
recapitulates RFP (upper panel). Scale bar = 100 µm. (Right panel) Confocal imaging of 5 dpf optic tectum
in the double transgenic embryos deriving from a cross of Tg(gSA2AzGFF49A) gene-trap line and Tg(UAS:
RFP,cry:GFP) (upper image) and Tg(UAS:Cas9T2AGFP;U6sgRNA1;U6sgRNA2) (lower image). Scale bar = 50
µm. No target sequence was inserted in the vector for the generation of the Tg(UAS:Cas9T2AGFP;
U6sgRNA1;U6sgRNA2) line.
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the number of GFP-positive cells in the
assay (Supplemental Fig. S1A). We there-
by transiently expressed the pUAS:
Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2
by injection into one-cell stage Tg(rpl5b:
Gal4) embryos. After separating the
pool of GFP-positive cells from the GFP-
negative control cells derived from 200
injected embryos, total DNA was ex-
tracted from the two cell populations.
Upon PCR amplification and sequencing
of single amplicons from the DNA of
GFP-positive cells, we detected indel
out-of-frame mutations at the tyr target
region in 30% (4/12) of the analyzed se-
quences (Supplemental Fig. S1B). In this
cell population, we also observed a 488-
bp deletion at the tyr gene resulting
from simultaneous targeting of the locus
by both sgRNAs. In contrast, no tyrmuta-
tions were found in the GFP-negative
cells (0/15). These data confirm that
locus-specific knockout events are re-
stricted to the cells expressing the fluo-
rescent reporter. Subsequently, we
tested whether spatiotemporally regulat-
ed tyr loss-of-function can be induced by
our vector system. For this purpose, we
used a transgenic line expressing Gal4
under the promoter of the zebrafish reti-
nal homeobox gene 2 (rx2) (Heermann
et al. 2015), Tg(rx2:Gal4;myl7:GFP). We
identified transgenic embryos using the
myl7 (myosin, light chain 7, regulatory)
promoter, driving heart-specific GFP ex-
pression, which was incorporated in the
same transgene. Rx2 is active in the optic primordium in the pro-
genitors of the neural retina and the retinal-pigmented epithelium
(RPE) (Chuang and Raymond 2001). Thus, transient, cell-specific
expression of Cas9 from the pUAS:Cas9T2AGFP;U6:tyrsgRNA1;
U6:tyrsgRNA2 in Tg(rx2:Gal4;myl7:GFP) embryos should promote
targeted disruption of the tyr locus uniquely in Gal4-positive cells,
leading to pigmentation defects exclusively in the RPE after bial-
lelic gene inactivation. In agreement with the known expression
pattern of the rx2 promoter (Supplemental Fig. S2A), we detected
sparse green fluorescent cells in the embryonic retina of Gal4-pos-
itive larvae, at 24 hours post-fertilization (hpf) (Fig. 2A). Of the em-
bryos analyzed at 5 days post-fertilization (dpf), 15%displayed loss
of pigmentation specifically in the RPE (16/107 embryos in three
independent experiments) compared to 0% (0/116 in three inde-
pendent experiments) in embryos injectedwith a plasmid contain-
ing control sgRNA sequences (Fig. 2B,C). We observed a variable
degree of pigmentation loss, and all the embryos displaying the
phenotypewere scored as positives. Importantly, no pigmentation
defects were detected outside of the eye-specific Gal4 expression
domain. Together, these results indicate that knockout of the tyr
gene driven by the rx2 promoter leads to tissue-specific pigmenta-
tion defects.Having this proof of principle for our approach,wede-
cided to create a stable integration of the UAS-based transgene to
achieve amore robust andmore reliable expression and to evaluate
the penetrance of the pigmentation phenotype. We generated a
Tg(UAS:Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2) transgenic line
and crossed it with Tg(rx2:Gal4;myl7:GFP) fish. Gal4-positive em-
bryos were prescreened by myl7:GFP expression and subsequently
analyzed to assess tyr inactivation. The rate of larvae displaying
RPE pigmentation defects increased to 48% (24/52) (Fig. 2D);
therefore, tyr loss-of-function most likely occurred in all double
transgenic progeny of the cross, as only half of the Gal4-positive
larvae were expected to carry the UAS transgene. This observation
shows that stable expression of the Cas9/sgRNA complex dramat-
ically improves the efficiency of gene inactivation, most likely
due to higher levels and more widespread expression in retinal
progenitor cells (RPCs). Based on these data, we conclude that
our vector system is capable of inducing loss-of-function alleles
at given genomic loci in a defined spatiotemporal manner.
However, at the developmental stage of the phenotypic analysis
(5 dpf), GFP fluorescence could no longer be detected since the
rx2 promoter is not active in the differentiated RPE. This result re-
flects the fact that GFP expression is strictly dependent on the
temporal activity of the promoter driving Gal4 expression, thus
restricting direct detection of potential mutant cells to a limited
time window.
Cre-mediated recombination allows permanent labeling
of Cas9-expressing cells
By using the pUAS:Cas9T2AGFP;U6:sgRNA1;U6:sgRNA2 vector,
potentially mutated cells are labeled by simultaneous expression
Figure 2. Tissue-specific disruption of the tyrosinase locus induced by the expression of the UAS-based
vector in the retinal progenitor cells. (A) Transmitted light and confocal imaging of eye of a 24 hpf Tg(rx2:
Gal4;myl7:GFP) embryo injected with pUAS:Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2 together with Tol2
mRNA. GFP fluorescence indicates Gal4-driven expression of the Cas9 enzyme in the retinal progenitor
cells (RPCs) giving rise to the retinal pigmented epithelium (RPE) and to the neural retina. Scale bar =
100 µm. (B) (Lower panel) Specific loss of pigmentation in the RPE of a 5 dpf zebrafish embryo induced
by injection of pUAS:Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2 in Tg(rx2:Gal4; myl7:GFP) at one-cell
stage. Arrowhead indicates the eye with lost pigmentation. (Upper panel) Control embryo injected
with the same vector containing a control sgRNA sequence (ctlsgRNA). Scale bar = 300 µm. (C) Frontal
view of eyes with absent pigmentation (lower panel) and wild-type (upper panel) explanted from the lar-
vae shown in B. (D) Table showing the percentage of Gal4-positive larvae displaying loss of pigmentation
in the RPE. (First row) Injection of the pUAS:Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2 into one-cell-stage
Tg(rx2:Gal4; myl7:GFP) embryos. (Second row) Cross of Tg(rx2:Gal4; myl7:GFP) fish with Tg(UAS:
Cas9T2AGFP;U6:tyrsgRNA1;U6:tyrsgRNA2).
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of the Cas9 endonuclease and a GFP reporter. Nevertheless, the
possibility of phenotypic analysis of the cells expressing the trans-
gene strongly depends on the activity window of the chosen pro-
moter, as it determines when the GFP reporter can be detected.
Therefore, the long-term visualization of cells displaying loss-of-
function phenotypes that are not self-revealing (unlike the loss
of pigmentation induced by mutations on the tyr locus) requires
permanent labeling of Cas9-expressing cells and their progeny.
To obtain such a labeling, we replaced the GFP ORF with the one
of Cre recombinase (Fig. 3A), an enzyme catalyzing site-specific re-
combination events (Branda and Dymecki 2004; Pan et al. 2005).
In order to detect Cre-mediated labeling of Cas9-expressing cells,
we used transgenic lines carrying a cassette where a ubiquitous
promoter drives constitutive expression of a fluorescent reporter
only upon excision of a floxed STOP sequence byCre recombinase.
The tissue-specific Gal4-driven transcription of a UAS:Cas9T2ACre
transgene ensures concomitant expression of the Cas9 and Cre
enzymes inducing, respectively, double-strand breaks (DSBs) at
the target locus and activation of the floxed reporter transgene
within the same cell (Fig. 3B). Most importantly, Cre-dependent
expression of the fluorescent reporterwill persist in all cells derived
from a specific Cas9-expressing precursor. This approach, that
we name 2C-Cas9 (Cre-mediated recombination for Clonal analy-
sis of Cas9 mutant cells) allows targeted mutagenesis of a cell
population and the genetic labeling of the derived mutant cell
clones.
Visualizing 2C-Cas9-mediated gene inactivation
In order to explore the possibility of directly visualizing protein
loss, we sought to induce eye-specific loss-of-function at the parval-
bumin 6 (pvalb6) locus, coding for a calcium-binding protein ex-
pressed in a subpopulation of amacrine cells (ACs) in the inner
nuclear layer (INL) and retinal ganglion cell layer (GCL) of the dif-
ferentiated retina (Fig. 4A). The pvalb6 gene is the only paralog ex-
pressed in mature retinal neurons as reported by the ZFIN in situ
database (Sprague et al. 2008). This gene represents an ideal target
for unbiased detection of locus disruption, since its expression can
be easily revealed by immunohistochemistry with a commercially
available antibody (Nevin et al. 2008). To achieve pvalb6 inactiva-
tion, we first generated a pUAS:Cas9T2ACre;U6:pvalb6sgRNA1;U6:
pvalb6sgRNA1 vector. The mutagenesis rate of the sgRNA used
was tested in transient injection in wild-type embryos prior
to cloning in the 2C-Cas9 vector (Supplemental Table S1). As a sin-
gle efficient sgRNA could be identified
for this gene, the same target sequence
was inserted downstream from each of
the two U6 promoters. We chose the
rx2:Gal4 driver to express this UAS con-
struct targeting pvalb6 in multipotent
retinal progenitor cells as the rx2 promot-
er is active during early eye field develop-
ment (Chuang and Raymond 2001;
Heermann et al. 2015). It has been previ-
ously reported that one single RPC can
give rise to clones including all of the dif-
ferent retinal cell types spanning all reti-
nal layers (Livesey and Cepko 2001).
Thus, a loss-of-function mutation,
when induced at the level of a RPC, is ex-
pected to propagate to a clone of cells de-
rived from the progenitor. To obtain
clonal labeling of mutant retinal cells,
we injected the pUAS:Cas9T2ACre;U6:
pvalb6sgRNA1;U6:pvalb6sgRNA1 into one-
cell stage embryos of a cross of Tg(rx2:
Gal4;myl7:GFP) and Tg(-3.5ubb:loxP-
lacZ-loxP-eGFP)cn2 fish. The latter
reporter line allows visualization of Cre-
mediated recombination by switching
from lacZ to GFP expression. This cross
enables the detection in the retina of ra-
dial columns of GFP-positive cells arising
from RPCs having expressed the Cas9
during the activation time of the rx2 pro-
moter. Discrete clones of GFP-positive
Cas9-expressing cells were analyzed in
retinas of 5 dpf larvae after double im-
munohistochemistry for GFP and Pvalb.
For each clone, we counted the total
number of cells labeled by the GFP re-
porter, excluding photoreceptors, and
the number of cells simultaneously
stained for GFP and Pvalb. This second
Figure 3. Permanent labeling of Cas9-expressing cells by Cre-mediated recombination. (A) Schematic
illustration of the pUAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 expression vector design. The vector contains
two U6-sgRNA expression cassettes targeting the same gene. BsaI and BsmBI restriction sites are used for
the sgRNA target sequence cloning. UAS elements drive the expression of Cas9 and Cre recombinase
linked via the T2A peptide. (B) Microinjection of the pUAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 construct
in the double transgenic embryos Tg(Tissue specific promoter:Gal4) × Tg(Ubiquitous promoter:loxP-STOP-
loxP-XFP) triggers simultaneous synthesis of Cas9 and Cre in a chosen spatiotemporal pattern, defined
by the promoter driving Gal4 expression. Cell-specific Cas9 endonuclease activity induces targeted dis-
ruption of the gene of interest and Cre-mediated recombination induces permanent expression of a fluo-
rescent reporter gene (XFP) by deletion of the floxed stop sequence.
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population represents the subset of amacrine cells deriving from
Cas9-expressing RPCs that escaped pvalb6 biallelic inactivation.
We observed that the total number of cells was not affected in
the examined clones (15 ± 1 in controls vs. 16 ± 1 in pvalb6
sgRNA clones; P = 0.9, Wilcoxon Mann–Whitney test), while the
number of cells showing colocalization of Pvalb and GFP signals
was considerably reduced by the targeting of pvalb6 (1.9 ± 0.3
in controls vs. 0.8 ± 0.2 in pvalb6 sgRNA clones; P < 0.005,
Wilcoxon Mann–Whitney test) (Fig. 4B). Overall, in control reti-
nas the number of GFP-positive cells expressing Pvalb represented
12% of each clone on average (n = 23 clones; 345 cells analyzed).
On the contrary, in clones where the pvalb6 gene was targeted,
only 4% of GFP-positive cells were also positive for Pvalb (n =
27 clones; 435 cells analyzed), representing cells that escaped
biallelic pvalb6 inactivation (Fig. 4C,D). Altogether, pvalb6 target-
ing led to a reduction of two thirds of the pvalb6-expressing
ACs. These results confirm that 2C-Cas9 can mediate gene loss-
of-function and that antibody staining can efficiently reveal pro-
tein loss at a cellular resolution, offering a clear read-out of the pro-
portion of cells carrying biallelic mutations within the analyzed
population.
atoh7 gene inactivation in retinal progenitors inhibits
determination of retinal ganglion cells (RGCs) in clonally
derived cell populations
We next wanted to test the utility of the 2C-Cas9 system in the
analysis of a loss-of-function phenotype in cell clones. We chose
to target the atonal bHLH transcription factor 7 (atoh7) gene because
a characterized loss-of-function allele (lakritz) shows a clearly iden-
tifiable retinal phenotype (Kay et al. 2001). The lak mutation re-
sults in the loss of retinal ganglion cell (RGC) specification
during eye development. Because rx2 expression precedes atoh7 ac-
tivation, mutations induced by rx2-driven Cas9 may give rise to
atoh7 mutant cells in RPCs before endogenous atoh7 is expressed.
We therefore transiently expressed a pUAS:Cas9T2ACre;U6:
atoh7sgRNA1;U6:atoh7sgRNA2 vector in double transgenic embry-
os deriving from a cross of Tg(rx2:Gal4;myl7:GFP) and Tg(-3.5ubb:
loxP-lacZ-loxP-eGFP)cn2 fish to induce targeted mutations at the
atoh7 locus in RPCs. The mutagenesis efficiency of the sgRNAs
used was assessed prior to insertion in the transgenesis vector
(Supplemental Table S1) in transient injection experiments.
Clones of GFP-positive cells were analyzed in sections of
Figure 4. Targeting of the pvalb6 locus leads to loss of Pvalb expression in ACs. (A) Schematic of a clone of cells deriving from a single RPC. The black
frame defines the position of the amacrine cell population. (ONL) Outer nuclear layer, (INL) inner nuclear layer, (GCL) ganglion cell layer. (B) GFP-positive
Cas9-expressing cells in the retinal section of a 5 dpf double transgenic Tg(rx2:Gal4; myl7:GFP) × Tg (-3.5ubb:loxP-lacZ-loxP-eGFP)cn2 embryos transiently
expressing the 2C-Cas9 vector containing control sgRNAs (upper panel) or pvalb6-specific sgRNAs (lower panel). The same sgRNA target sequence was in-
serted downstream from each U6 promoter (U6:pvalb6sgRNA1). The number of Pvalb- and GFP-double-positive cells (black dots) is reduced if pvalb6 is
targeted compared to control. Scale bar = 50 µm. (C ) Quantification of the percentage of Pvalb-positive cells per GFP-positive clone. Data are represented
as mean ± SEM. (∗∗∗) P-value < 0.001 following Wilcoxon Mann–Whitney test. (D) Table showing the percentage of Pvalb-positive cells per GFP-positive
clone in the retinal sections of double transgenic Tg(rx2:Gal4; myl7:GFP) × Tg(-3.5ubb:loxP-lacZ-loxP-eGFP)cn2 larvae microinjected with the 2C-Cas9 plas-
mid containing control sgRNAs (first row) or pvalb6-targeting sgRNAs (second row).
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differentiated retinas of 5 dpf larvae (Fig. 5A–C). For this analysis,
we chose to quantify only spatially well-separated clones that
could be unambiguously identified, ranging from 10 to 55 cells
per clone. We observed that the total number of cells per clone
was not affected (25 ± 3 in controls vs. 24 ± 2 in atoh7 sgRNA
clones; P = 0.91, Wilcoxon Mann–Whitney test), while the num-
ber of RGCs was significantly reduced in atoh7 targeted clones
(6.1 ± 1.2 in controls vs. 2.4 ± 0.5 in atoh7 sgRNA clones; P < 0.01,
Wilcoxon Mann–Whitney test). On average, in control retinas
the RGC population represented 23% of the cells in each clone
(57/247 cells analyzed). In contrast, in potentially atoh7-depleted
clones only 9% of GFP-positive cells corresponded to differentiat-
ed RGCs (48/532 cells analyzed) (Fig. 5D). In the retinas of
embryos injected with the control plasmid, all clones of cells
(10/10) contained RGCs, representing, in the majority of clones
(7/10), >20% of the GFP-positive cell population (Fig. 5E). In the
retinal sections of embryos where the atoh7 locus was targeted,
one third of the examined clones (7/22) displayed complete ab-
sence of RGCs, while only in a few cases (2/22 clones) the percent-
age of specified RGCs per clone was higher than 20% (Fig. 5E).
These observations indicate that atoh7 loss-of-function is effec-
tively induced by our vector system in rx2-expressing retinal
progenitors.
Analysis of genetic chimeras by combining tissue-specific
loss-of-function with Brainbow single-cell labeling
To gain insights into complex loss-of-function phenotypes, it is
necessary to understand if the biological effect of gene inactiva-
tion is cell-autonomous or non-cell-autonomous. Our method
can be applied to generate genetic mosaics in which the pheno-
type of single mutant cells can be analyzed in a wild-type
Figure 5. Clonal deletion of atoh7 leads to reduction in RGCs differentiation. Targeting of the atoh7 gene. Atoh7 is a transcription factor essential for the
differentiation of retinal ganglion cells (RGCs). The pUAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 construct,with control or atoh7-specific sgRNAs, was injected
in double transgenic embryos Tg(rx2:Gal4; myl7:GFP) × Tg(-3.5ubb:loxP-lacZ-loxP-eGFP)cn2. The latter transgene drives Gal4 expression in retinal progen-
itor cells. (A) (Upper panel) Differentiated RGCs are detected in wild-type clones injected with the DNA construct containing control sgRNAs. (Lower panel)
GFP-labeled mutant clones show reduction of RGCs in the retinal section of a 5 dpf larva, as expected from atoh7 loss-of-function. Quantification of RGCs
was done according to soma location in the ganglion cell layer (GCL), and displaced amacrine cells were distinguished by Parvalbumin counterstaining.
Scale bar = 100 µm. (B) Higher magnification of the wild-type (upper panel) and atoh7 (lower panel) mutant retinal cell layers. RGCs are indicated by as-
terisks. (C) A schematic of labeled clones in the zebrafish retinal layers. (ONL) Outer nuclear layer, (INL) inner nuclear layer, (GCL) ganglion cell layer. (D)
Quantification of the percentage of RGCs per clone derived from Cas9-expressing cells. Data are represented as mean ± SEM. (∗∗∗) P-value < 0.001 follow-
ing Wilcoxon Mann–Whitney test. (E) Table showing the percentage of RGCs per GFP-positive clone in the retinal sections of double transgenic Tg(rx2:
Gal4; myl7:GFP) × Tg(-3.5ubb:loxP-lacZ-loxP-eGFP)cn2 embryos microinjected with the 2C-Cas9 vector containing control sgRNAs (first row) or atoh7-spe-
cific sgRNAs (second row).
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background, thus allowing the evaluation of cell-autonomous
gene function. To this end, we combined our conditional knock-
out strategy with the Brainbow technology (Livet 2007; Pan et al.
2013), in which Cre recombinase stochastically activates the ex-
pression of different fluorescent proteins, allowing the differential
labeling of single mutant cells in a wild-type tissue. In
the UAS:Brainbow transgene (Tg[UAS:Br1.0L]s1997t) (Robles et al.
2013), Cre recombinase sites separate the cDNAs of the fluores-
cent proteins tdTomato, Cerulean, and YFP. When crossing a
transgenic line carrying this cassette to cell-type–specific Gal4
lines, the Gal4 transactivator leads to the expression of
tdTomato, in the absence of Cre-mediated recombination. In con-
trast, if Cre recombinase expression is induced, transcription of ei-
ther cerulean or YFP is triggered (Fig. 6A). We first verified that
transient expression of the pUAS:Cas9T2ACre;U6:sgRNA1;U6:
sgRNA2 construct induces stochastic recombination of the
UAS:Brainbow allele by injecting the plasmid into one-cell stage
Tg(rpl5b:Gal4) or Tg(mnx1:Gal4) × Tg(UAS:Br1.0L)s1997t double
transgenic embryos. Mosaic expression of fluorescent proteins
was detected, as expected, in Gal4-positive cells (Fig. 6B) in agree-
ment with the known Gal4 expression patterns of the two
promoters (Fig. 1B; Supplemental Fig. S2B). We next used the
2C-Cas9 vector system to generate genetic chimeras where
tdTomato- fluorescent cells are wild-type, while Cerulean- or
YFP-labeled cells represent potentially mutant cells. In order to
achieve this differential labeling, we injected the 2C-Cas9 vector
in double transgenic embryos (carrying tissue-specific Gal4 driver
and UAS:Brainbow). In our construct, Cas9 and Cre expression oc-
cur from the same transcript; therefore, Gal4-expressing cells that
received the Cas9T2ACre plasmid will recombine the UAS:Br1.0L
allele, inducing expression of cerulean or YFP and will potentially
be knockout for the target gene. On the contrary, Gal4-expressing
cells that did not receive the Cas9T2ACre plasmid will be marked
by tdTomato fluorescence and wild-type (Fig. 6A).
Figure 6. Labeling of mutant single cells by combining the
2C-Cas9 and the Brainbow methodologies. (A) Microinjection
of the pUAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 construct in the
double transgenic embryos Tg(promoter:Gal4) × Tg(UAS:
Brb1.0L)s1997t leads to synthesis of both Cas9 and Cre. In
Gal4-expressing cells, Cas9 promotes targeted cleavage of the
chosen genomic locus. At the same time, Cre activity induces
stochastic recombination of the UAS:Brb1.0L cassette, thus pro-
moting a switch from the default tdTomato to YFP or Cerulean
fluorescence in the same cells. (B) Recombination of the UAS:
Brb1.0L cassette in a tissue-specific pattern induced by injection
of the pUAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 plasmid. No tar-
get sequence was inserted in the vector prior to injection. (Left
panel) Multicolor labeling of muscle cells in the Tg(rpl5b:Gal4)
transgenic line. (Right panel) Single YFP motor neuron labeled
by expression of UAS:Cas9T2ACre;U6sgRNA1;U6sgRNA2 trans-
gene in the double transgenic embryos Tg(mnx1:Gal4) × Tg
(UAS:Brb1.0L)s1997t. tdTomato marks motor neurons that do
not express the UAS transgenic cassette. Scale bar = 50 µm.
(C) Double transgenic Tg(isl2b:Gal4; kif5aa∗162/+-) × Tg(UAS:
Brb1.0L)s1997t larva, injected with pUAS:Cas9T2ACre;U6:
Kif5aasgRNA1;U6:Kif5aasgRNA2. isl2b:Gal4 drives the expression
of UAS:Brb1.0L transgene in RGC axons in the optic tectum.
Note that the axonmarked by cerulean expression, and therefore
by Cre recombinase activity, shows reduced arbor size as expect-
ed from the phenotype of kif5aa−/− RGCs transplanted in wild-
type host (Auer et al. 2015). Scale bar = 30 µm. (D)
Quantification of total branch length in tdTomato-positive
wild-type and potentially mutant Cerulean- or YFP-positive
RGC axons (analyzed in kif5aa+/+: [∗] P-value < 0.05 following
Wilcoxon Mann–Whitney test, and kif5aa∗162/+: [∗∗∗] P-value <
0.001 following Wilcoxon Mann–Whitney test). Data are repre-
sented as mean ± SEM. (E) Table describing the percentage of
RGCs displaying a wild-type-like (axonal length > 200 µm) and
a mutant-like (axonal length < 200 µm) phenotype in the tec-
tum of double transgenic Tg(isl2b:Gal4; kif5aa∗162/+-) × Tg
(UAS:Brb1.0L)s1997t larva, injected with pUAS:Cas9T2ACre;U6:
Kif5aasgRNA1;U6:Kif5aasgRNA2. (First row) tdTomato-positive
cells (UAS:Cas9T2ACre;U6:Kif5aasgRNA1;U6:Kif5aasgRNA2-neg-
ative). (Second row) Cerulean- or YFP-positive neurons (UAS:
Cas9T2ACre;U6:Kif5aasgRNA1;U6:Kif5aasgRNA2-positive) in
kif5aa+/+fish. (Third row) Cerulean- or YFP-positive neurons
(UAS:Cas9T2ACre;U6:Kif5aasgRNA1;U6:Kif5aasgRNA2-positive)
in kif5aa∗162/+fish.
Genome Research 687
www.genome.org
Cas9 and Cre coexpression for clonal analysis
 Cold Spring Harbor Laboratory Press on June 30, 2016 - Published by genome.cshlp.orgDownloaded from 
To confirm that cell-autonomous gene function can be exam-
ined by this method, we targeted the kif5aa gene, coding for the
motor protein Kinesin family member 5A, a (Campbell and
Marlow 2013; Auer et al. 2015). We selected this gene because
we have recently shown that kif5aa inactivation results in the re-
duction of axon arbor complexity via a cell-autonomous mecha-
nism: kif5aa−/− cells transplanted into wild-type host, after
differentiation into RGCs, showed a severe reduction in axon arbor
total length (Auer et al. 2015). We decided to apply the 2C-Cas9
system to inactivate the kif5aa gene in single RGCs while differen-
tially labeling wild-type and potentially mutant cells in the same
embryos. We used Tg(isl2b:Gal4) larvae to express the Gal4 trans-
activator in RGCs and drive 2C-Cas9-mediated gene disruption
in this neuronal population. To further increase the efficiency of
the knockout strategy, we used Tg(isl2b:Gal4) embryos heterozy-
gous for an existing loss-of-function mutation in the kif5aa locus
(kif5aa∗162/+). We hypothesized that, if only one wild-type allele
needs to be targeted by the Cas9/sgRNA complex, a loss-of-func-
tion phenotype would be generated with a higher probability.
We therefore cloned two sgRNAs targeting the kif5aa locus (Auer
et al. 2014b) (Supplemental Table S1) in the 2C-Cas9 vector and
injected the resulting pUAS:Cas9T2ACre;U6:kif5aasgRNA1;U6:
kif5aasgRNA2 in double transgenic embryos Tg(isl2b:Gal4;
kif5aa∗162/+) ×Tg(UAS:Br1.0L)s1997t. In the injected embryos,
YFP- or Cerulean-fluorescent RGCs (potentially kif5aa mutant)
showed a decrease of total branch length compared to tdTomato-
expressing RGCs (wild-type). As expected, an overall reduction of
axonal length was detected in YFP or Cerulean RGCs compared
to tdTomato RGCs, and it was more severe in kif5aa∗162/+ than in
kif5aa+/+ embryos (tdTomato-expressing RGCs = 261.8 ± 19.3 µm,
n = 6; cerulean- or YFP-expressing RGCs in kif5aa+/+ = 188.8 ± 15.7
µm, n = 11, P < 0.05, Wilcoxon Mann–Whitney test; cerulean- or
YFP-expressing RGCs in kif5aa∗162/+ = 156.6 ± 7.7 µm, n = 11, P
<0 .001, Wilcoxon Mann–Whitney test) (Fig. 6D). In addition,
we noted the presence of two distinct RGC phenotypes in the
Cre-labeled neurons: a wild-type-like (axonal length >200 µm)
and amutant-like (axonal length <200 µm). Remarkably, the num-
ber of cells showing a mutant-like phenotype was more abundant
in the kif5aa∗162/+ fish (91% of analyzed axons, n = 11) than in the
kif5aa+/+ embryos (64% of analyzed axons, n = 11) (Fig. 6E). This
observation confirms that the activation of the 2C-Cas9 system
in a heterozygous genetic background leads to an increase of the
proportion of mutant cells.
Our results demonstrate the utility of thismethod to generate
genetic mosaic embryos and allow the labeling of multiple axons
with different genotypes in distinct color combinations.
Discussion
The constant improvement of CRISPR/Cas9-mediated technolo-
gies over the past years is revolutionizing reverse genetic approach-
es in model organisms. Using the Gal4/UAS system for the first
time in a vertebrate model to drive Cas9 expression, our method
expands the possibility of spatiotemporally regulated gene knock-
out, allowing researchers to tap into the resource of existing Gal4
driver lines. The generation of a stable Tg(UAS:Cas9T2AGFP;U6:
sgRNA1;U6:sgRNA2) transgenic line, represents an advantage in
the study of in vivo gene function in diverse cell types and tissues,
as tissue-specific gene inactivation can be obtained simply by
crossing to already established Gal4 driver lines. Although this
transgenic expression system has been shown to experience
somatic mosaicism from epigenetic silencing (Akitake et al.
2011), this has not diminished its great popularity and use in
zebrafish and other organisms. Indeed, in some applicationsmosa-
ic gene expression can even be a positive feature, allowing the anal-
ysis of the effect of gene inactivation in a sparse manner in single
cells or cell clones. However, even when tissue-specific gene inac-
tivation is achieved, the visualization ofmutant cells is essential to
the phenotypic analysis, an integral element that was not possible
with previously published approaches.
In our work, we tested two methods to identify cells carrying
loss-of-function alleles. In both cases, the use of a T2A self-cleaving
peptide allows for the stoichiometric expression of the Cas9 and a
reporter gene that are translated as a single polypeptide from the
same mRNA (Provost et al. 2007; Kim et al. 2011). First, we used
a GFP reporter whose expression is linked to that of the Cas9
to allow for efficient visualization of Cas9-expressing cells.
Cas9T2AGFP transcription being dependent on transactivation
by Gal4, the analysis of gene loss-of-function can be performed
during the time frame of Gal4 expression, which is detected by
GFP fluorescence. In some cases, the phenotypic evaluation ofmu-
tant cellsmaybe required afterGal4 expressionhas terminated. For
instance, when targeting the tyr gene with a Gal4 driver active in
retinal progenitors, we could observe cells lacking pigmentation
in larvae, but they did not express GFP, and therefore, absence of
pigmentation could not be strictly correlated to inactivation of
the tyrosinase gene in the unpigmented cells. The second method
that we tested, 2C-Cas9, addresses the time frame issue by enabling
both conditional generation of mutant cells and their permanent
lineage tracing. In this assay, we used Cre activity to permanently
label the population ofCas9-expressing cells, making it possible to
analyze the phenotype resulting from targeted gene disruption af-
ter Cas9 expression has ceased. Importantly, if Cre-mediated re-
combination of a floxed allele results in the expression of a
fluorescent protein driven by a constitutive promoter, the label
would be transmitted from the Cas9-expressing founder cell to
its progeny and remain detectable, thus generating a clone of la-
beled mutant cells. By using this method in retinal progenitor
cells, we successfully disrupted the pvalb6 and atoh7 genomic
loci, thus modifying molecular identity and cell-fate determina-
tion of their progeny, respectively.
To expand further the possibility to analyze tissue-specific
gene inactivation, we took advantage of the flexibility of the
pUAS:Cas9T2ACre;U6:sgRNA1;U6:sgRNA2 construct to achieve la-
beling of single mutant cells in an otherwise wild-type animal.
So far, generation of genetic chimeras in biological systems has
mainly been possible in the mouse and the fruit fly, greatly con-
tributing to the preeminence of these animal models in genetic
studies (Perrimon 1998; Wijgerde et al. 2002). In these models,
the use of recombination-based approaches such as Cre/LoxP has
been accepted as a gold standard technique for conditional muta-
genesis. Until now, a similar approach has not been available in
zebrafish. The phenotypic analysis of single mutant cells in a
wild-type genetic background has relied on technically challeng-
ing transplantation experiments limited to embryonic develop-
ment, which could not be temporally controlled. For this reason,
genetic chimera experiments allow the investigation of only early
phenotypes and cannot be used to examine the role of genes and
pathways that are used repeatedly during development. Our
multicolor labeling approach, that we achieved by combining
the 2C-Cas9 system with the Brainbow technology (Livet 2007;
Pan et al. 2013), permits the analysis of tissue-specific phenotypes
of gene inactivation at a single cell resolution and enables the di-
rect comparison of potentially mutant cells with their wild-type
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counterpart in the same animal. Cre/LoxP-based approaches in
zebrafish, if properly developed, could also circumvent these
limitations but would require much longer generation time
and challenging homologous recombination-based genomic
manipulations. Furthermore the efficiency of Cre-mediated re-
combination is well known to depend strongly on the Cre driver
line used and the target locus, and potential mosaic inactivation
needs to be taken into account also in this case (Branda and
Dymecki 2004).
Although the 2C-Cas9 system is meant to allow the pheno-
typic evaluation of mutant cells, different parameters may influ-
ence the interpretation of phenotypes arising from the targeting
of a specific locus with this method. To unambiguously follow
the fate of mutant cells (or clones of cells), it would be necessary
to activate a reporter gene exclusively in these populations.
However, in the zebrafish model system, the tools to obtain this
kind of tracking are still missing. As an alternative, we propose
to mark potentially mutant cells by coexpressing the Cas9 en-
zyme together with GFP or Cre reporters. By using this approach,
not all the analyzed cells will be mutant and each mutant cell will
have independently induced mutations (a percentage of these
might be silent in-frame mutations). If an antibody recognizing
the protein encoded by the targeted gene is available, a single
staining could identify all the cells carrying protein null-muta-
tions. Indeed, we could reveal pvalb6 loss-of-function in the
zebrafish neural retina by staining the population of Cas9-ex-
pressing cells with an antibody directed against this protein. In
other cases, a molecular evaluation of the proportion of truly mu-
tant cells within the analyzed population would be ideally need-
ed to facilitate the statistical analysis of the behavior of the Cas9-
expressing cells. A possibility to estimate the rate of mutation in
the targeted tissue would be the separation of the marked Cas9-
expressing cells by fluorescence-activated cell sorting (FACS). To
be efficient, this procedure requires a highly pure and concentrat-
ed single-cell suspension, and it might be prone to contamination
with debris or nonfluorescent cells. In addition, many transgenic
lines contain fluorescent transgenesis markers (such as myl7:GFP
or cry:GFP), which are wild-type fluorescent cells limiting the ac-
curacy of the FACS for the evaluation of the mutagenesis
efficiency.
In addition, the strength of the Gal4 driver used is essential in
determining the efficiency of the 2C-Cas9 system, and its variabil-
itymay result in differences in gene disruption. For instance, when
using the Tg(rpl5:Gal4) line to target the tyr locus, we detected a
mutagenesis rate that appeared lower than when using the rx2:
Gal4 driver, where we observed phenotypes suggesting a highly ef-
ficient gene disruption. This result suggests that, in driver lines dis-
playing low expression of the Gal4 transactivator, gene
inactivation may be insufficient to observe phenotypic effects of
loss-of-function. Therefore strong Gal4 carrier lines need to be
used in order to achieve high mutagenesis rates. The intra-cellular
levels of Cas9 expression provided by the 5×UAS of our vector sys-
tem were sufficient to induce gene inactivation in cell clones or
single cells in our experiments. Nevertheless, further improve-
ments in the Cas9 expression cassette could increase Cas9 protein
levels. Recently, noncoding elements of the zebrafish genome
have been used to increase expression of transgenes and have
been incorporated in UAS vectors (Horstick et al. 2015). The addi-
tion of such features to our vector designmay have a strong impact
on the expression of theCas9, thus leading to amore penetrant tis-
sue-specific loss-of-function. In addition to strong and stable Cas9
expression, the generation of a high rate of biallelic mutations re-
quires highly active sgRNAs that will be facilitated by recently re-
ported efficiency predictions (Moreno-Mateos et al. 2015).
Furthermore, the design of sgRNAs recognizing genomic loci cod-
ing for essential domains of a protein would increase the possibil-
ity of inducing a null phenotype, even in the case of in-frame
mutations (Shi et al. 2015). Importantly, we also show that one
simple and powerful way to increase the efficiency of gene disrup-
tion is to inject the pUAS:Cas9T2ACre;U6:sgRNA1;U6:sgRNA2 in a
heterozygousmutant background, where one allele is already con-
stitutively mutated.
In this report, we present for the first time in zebrafish a strat-
egy to track the fate of individual geneticallymodified cells within
awild-typewhole animal environment, thus allowing detection of
cell-autonomous defects resulting from mutations. The genetic
lineage tracing of potentially mutant cells allows the phenotypic
analysis of cell populations of interest until adulthood, broadening
the use of the 2C-Cas9 in fields ranging from stem cells and regen-
eration to cancer biology and aging. Finally, because none of the
tools that we generated are restricted to zebrafish, similar experi-
ments are readily possible in virtually any organism where trans-
genesis and DNA injection are feasible.
Methods
Fish lines and husbandry
For this study, the transgenic and mutant lines used are listed in
Supplemental Table S2. Zebrafish strains were maintained accord-
ing to standard protocols (Westerfield 2000).
Molecular cloning
The Cas9T2AGFP fragment was generated by inserting a PCR-am-
plified fragment containing the T2AGFP sequence from the
pCas9_GFP plasmid (Addgene, #44719) into the pCS2-nCas9n
plasmid (Addgene, #47929). Primers used (5′ to 3′) were bglII-
Cas9-T2A fwd: GGTGAGATCTCCTAAGAAGAAGAGAAAGGTGA
GGTCCGGCGGCGGAG, and GFP XbaI rev: AGCTTCTAGATTA
CTTGTACAGCTC. BglII and XbaI enzymes were used to digest
both plasmid and PCR product prior to ligation.
The U6:sgRNA1 sequence was synthetized as G-block from
IDT. BsmbI restriction sites were introduced to clone the 20-bp
target sequence at the predicted transcription start site (+1).
The Gibson assembly kit (NEB) was used to clone the U6:sgRNA1
and the Cas9T2AGFP fragments into a pminiTol2 vector
(Balciunas et al. 2006) containing a 5×UAS cassette and digested
with EcoRI and ClaI. Primers used were (5′ to 3′): U6 fwd:
GCAATAAACCTTGTACAAAGTGGGGGATC, and U6 rev: GAGC
TCGAATTAATTCATAATTGAAAAAAAGCACCGAC to amplify the
U6:sgRNA fragment, and Cas9-T2A-GFP fwd: CTGAATAGGGAA
TTGGGGCCACCATGGCTTCTCCA, and Cas9-T2A-GFP rev: TTG
TACAAGGTTTATTGCAGCTTATAATGGTTACAAATAAAG to am-
plify the Cas9T2AGFP fragment.
The second U6:sgRNA2 cassette was designed with SalI over-
hangs for insertion into the p(UAS:Cas9T2AGFP;U6:sgRNA1) plas-
mid linearized with the same enzyme. BsaI sites were used to clone
the 20-nt sgRNA target sequence at the +1 position.
The Cas9T2ACre fragment was synthetized by fusion of indi-
vidual PCR products using PhusionHigh-Fidelity DNA Polymerase
(Thermo Scientific). The Cre sequence was amplified from the
pCR8GW-Cre-FRT-kan-FRT 2 plasmid (Suster et al. 2011). Primers
used (5′ to 3′) were T2A-Cre fwd: GAGGAAGTCTTCTAACAT
GCGGTGACGTGGAGGAGAATCCCGGCCCAATGGCCAATTTAC
TGACCGTACAC, and Cre-XbaI rev: CGATTCTAGACTAATCGCC
Cas9 and Cre coexpression for clonal analysis
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ATCTTCCAGC. The Cas9T2A fragment was amplified from the
pUAS:Cas9T2AGFP;U6:sgRNA1;U6sgRNA2. Primers used (5′ to 3′)
were Cas9 KpnI fwd: GGTCGGTACCGCACTGATCAAGAAATAC,
and T2A rev: GTCACCGCATGTTAGAAGACTTCC. Both frag-
ments were fused, amplified, and inserted into the pUAS:Cas9T
2AGFP;U6:sgRNA1;U6sgRNA2 digested with KpnI and XbaI. The
sequence of all constructs was verified by sequencing.
Generation of stable transgenic lines
The Tg(UAS:Cas9T2AGFP;U6:sgRNA1;U6:sgRNA2) and Tg(UAS:
Cas9T2AGFP; U6:tyrsgRNA1;U6:tyrsgRNA2) were generated by in-
jecting the previously described plasmids into one-cell stage
wild-type embryos. The rx2:Gal4 vector was generated by three-
way-Gateway cloning recombining a 5′ entry vector carrying the
rx2 promoter fragment (Heermann et al. 2015) with a Gal4middle
entry, a polyA 3′entry vector, and a myl7:eGFP-Tol2 destination
vector (Kwan et al. 2007). To generate the rpl5b:Gal4 vector, we
cloned a 5700-bp promoter fragment of the ribosomal gene rpl5b
in a 5′ entry vector and recombined it with a Gal4 middle entry,
a polyA 3′ entry vector, and a Tol2 destination vector (Kwan
et al. 2007). To generate the Tg(-3.5ubb:loxP-lacZ-loxP-eGFP)cn2
transgenic line (also known as cn2Tg or Hulk), we used a three-
way-Gateway cloning system. p5E -3.5ubb:loxP-lacZ-loxP was gen-
erated by inserting the result of digesting the iZEG plasmid (Novak
et al. 2000) with XbaI and XhoI and making blunt ends into the
p5E ubi (Mosimann et al. 2011) after being linearized with
BamHI and blunting the ends. pDest cry:GFP was generated by in-
serting the result of digesting the p1 cry:GFP (Love et al. 2011) with
SacII and making blunt ends into the pDestTol2pA2 (Kwan et al.
2007) that was linearized with BglII. The -3.5ubb:loxP-lacZ-loxP-
eGFP; cry:GFP construct was generated combining these four plas-
mids into a single one using Gateway LR Clonase II, Life
Technologies: p5E -3.5ubb:loxP-lacZ-loxP, pME GFP (Kwan et al.
2007), p3E pA (Kwan et al. 2007), and pDest cry:GFP. Stable trans-
genic lineswere generated injecting plasmidDNAwithTol2mRNA
transposase and founders identified by genetic crossing and trans-
gene transmission. The cry:GFP cassette contained in this trans-
gene allows the selection of transgenic embryos due to the GFP
expression in the developing lens under the control of the
gamma-crystallin promoter.
Injections
To test the mutagenesis efficiency of sgRNAs, a mixture of sgRNA
and Cas9mRNA was injected into one-cell stage zebrafish embry-
os. The final concentrationwas 75 ng/µL for sgRNA and 150 ng/µL
for Cas9 mRNA. For Tol2-mediated transgenesis, p(UAS:
Cas9T2AGFP;U6:sgRNA1;U6sgRNA2) or p(UAS:Cas9T2ACre;U6:
sgRNA1;U6sgRNA2) were co-injected at a concentration of 30 ng/
µL with the Tol2 transposase mRNA (50 ng/µL) into the selected
Tg(Promoter:Gal4) lines. Genomic DNA was extracted from either
single embryos or pools of embryos and then used for PCR and
DNA sequencing experiments.
Whole-embryos DNA extraction
For genomic DNA extraction, pools of 25 embryos at 5 dpf were di-
gested for 1 h at 55°C in 0.5 mL lysis buffer (10 mM Tris, pH 8.0,
10 mM NaCl, 10 mM EDTA, and 2% SDS) with proteinase K
(0.17 mg/mL, Roche Diagnostics). To check for frequency of indel
mutations, target genomic loci were PCR-amplified using Phusion
High-Fidelity DNA polymerase (Thermo Scientific). PCR ampli-
cons were subsequently cloned into the pCR-bluntII-TOPO vector
(Invitrogen). Plasmid DNA was isolated from single colonies and
sent for sequencing. Mutant alleles were identified by comparison
with the wild-type sequence.
Cryosections
Embryos at the stage of 5 dpf were fixed in 4% paraformaldehyde
in PBS (pH 7.4) for 2 h at room temperature and subsequently cry-
oprotected overnight in a 30% sucrose/0.02% sodium azide/PBS
solution. Embryoswere transferred to plasticmolds and embedded
in OCT after removal of the sucrose. The blocks were placed on dry
ice before sectioning. The sections were cut with a thickness of
14 µm and mounted on Fisherbrand Superfrost plus slides (No.
12- 550-15).
Immunohistochemistry
Cryosections of 5 dpf retinas were washed twice in 1× PBS/0.1%
Tween-20 (PBS-T) solution. Subsequently, they were incubated
1 h at room temperature in 10% normal goat serum (Invitrogen)
in PBS-T blocking solution followed by overnight incubation
with 1/500 dilution of chicken primary anti-GFP (Genetex) or
mouse anti-Parvalbumin antibody (Millipore). The Alexa Fluor
488 secondary antibody goat anti-chicken IgG or the Alexa Fluor
568 secondary antibody goat anti-mouse IgG (1/500, Molecular
Probes) and a 1/500 dilution of DAPI (50 µg/µL) in blocking solu-
tionwere added for 2 h at room temperature. After fivewashings in
wash buffer (1× PBS/0.1% Tween-20) coverslips were placed on the
slides after addition of Vectashield drops. Slides were left at room
temperature for 1 h before microscopy analysis.
sgRNAs and Cas9 mRNA generation
sgRNA sequences (listed in Supplemental Table S1) were cloned
into the BsaI-digested pDR274 (Addgene, #42250) vector. The
sgRNAs were synthetized by in vitro transcription (using the
Megascript T7 transcription kit #AM1334, Ambion). After tran-
scription, sgRNAs were purified using an RNAeasy Mini Kit
(Qiagen). The quality of purified sgRNAs was checked by electro-
phoresis on a 2% agarose gel. As a control, we used RFP-specific
sgRNAs, whose sequence is not present in the fish genome
(Supplemental Table S1). Cas9 mRNA was generated as described
previously (Hwang et al. 2013a).
FACS
Fluorescent Cas9-expressing cells were isolated from wild-type
cells by fluorescence-activated cell sorting. 3 dpf embryos were
dissociated as previously described by Manoli and Driever
(2012). Cell sorting was performed on FACS Aria (BD
Biosciences), and data were analyzed using FACSDiva version
6.1.2 (BD Biosciences). The GFP fluorescence was detected in the
gfpBlue-B-530/30-A channel. GFP-positive and -negative cells
were sorted in lysis buffer provided in the NucleoSpin Tissue Kit
(Macherey-Nagel), and genomic DNA was extracted with the
same kit. PCR on target genomic loci and DNA sequencing were
performed as described above.
Microscopy
Low magnification images were acquired with a Leica MZ FLIII
stereomicroscope (Leica) equipped with a Leica DFC310FX digital
camera (Leica).Whole-eye pictures were takenwith a Leica upright
wide-field epifluorescence microscope using a 20× oil immersion
objective. A Zeiss LSM 780 confocal microscope (Zeiss) was
used for confocal microscopy, employing a 40× water immersion
or 10× objective. Z-volumes were acquired with a 1- to 2-μm
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resolution, and images were processed using ImageJ, Adobe
Photoshop, and Adobe Illustrator software.
Data access
The sequences of mutant tyr clones from this study have been
submitted to the NCBI GenBank (http://www.ncbi.nlm.nih.gov/
genbank/) under accession numbers KU751772–KU751776. The
sequences and the maps relative to the plasmids pUAS:
Cas9T2AGFP;U6:sgRNA1;U6:sgRNA2 and pUAS:Cas9T2ACre;U6:
sgRNA1;U6:sgRNA2 are available in Addgene (https://www.
addgene.org). Plasmid numbers are #74009 and #74010.
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